SHANDON, INC. – Trademark Portfolio
Entity Type: 03
SHANDON, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include MUCOLEXX, CYTOSLIDE, AQUA-MOUNT, and CYTOFUNNEL. The owner is based in PITTSBURGH, PA.
171 INDUSTRY DR.
PITTSBURGH, PA 15275
Showing of trademarks Trademarks
Trademark Classifications
SHANDON, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SHANDON, INC. have?
SHANDON, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 8 cancelled.
What trademark classes does SHANDON, INC. file in?
SHANDON, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SHANDON, INC.'s most well-known trademarks?
SHANDON, INC.'s registered trademark portfolio includes well-known marks such as MUCOLEXX, CYTOSLIDE, AQUA-MOUNT, and CYTOFUNNEL. These are among 4 currently registered trademarks in the portfolio.
What is SHANDON, INC.'s trademark registration success rate?
SHANDON, INC. has a 29% trademark registration rate, with 4 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.